Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets.
暂无分享,去创建一个
Kathrin Heikamp | Jürgen Bajorath | Dilyana Dimova | Dagmar Stumpfe | J. Bajorath | Dagmar Stumpfe | Kathrin Heikamp | D. Dimova
[1] Jürgen Bajorath,et al. Comprehensive Analysis of Single‐ and Multi‐Target Activity Cliffs Formed by Currently Available Bioactive Compounds , 2011, Chemical biology & drug design.
[2] Abhishek Tiwari,et al. Workflow based framework for life science informatics , 2007, Comput. Biol. Chem..
[3] Jürgen Bajorath,et al. Frequency of Occurrence and Potency Range Distribution of Activity Cliffs in Bioactive Compounds , 2012, J. Chem. Inf. Model..
[4] J. Bajorath,et al. Activity landscape representations for structure-activity relationship analysis. , 2010, Journal of medicinal chemistry.
[5] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[6] Jürgen Bajorath,et al. Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.
[7] Jameed Hussain,et al. Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets , 2010, J. Chem. Inf. Model..
[8] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[9] Jürgen Bajorath,et al. MMP-Cliffs: Systematic Identification of Activity Cliffs on the Basis of Matched Molecular Pairs , 2012, J. Chem. Inf. Model..